These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38213293)

  • 1. Neonatal Opioid Withdrawal Syndrome Following Prenatal Use of Supplements Containing Tianeptine.
    Ikeri K; Anderson A; Eyal F; Whitehurst R
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38213293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal Abstinence Syndrome Following Tianeptine Dependence During Pregnancy.
    Bence C; Bonord A; Rebillard C; Vaast P; Alexandre C; Jardri R; Rolland B
    Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26659818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Buprenorphine-Naloxone in the Treatment of Tianeptine Use Disorder.
    Trowbridge P; Walley AY
    J Addict Med; 2019; 13(4):331-333. PubMed ID: 30550394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Online Sales of Unscheduled Pharmaceutical Agents: A Case Report of Tianeptine Use in the United States.
    Gupta S; Wallace R; Sloshower J
    J Addict Med; 2017; 11(5):411-412. PubMed ID: 28742625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nursing Implications for Tianeptine Use and Misuse.
    Hargett JL; Lowry PF; Lee KN
    J Addict Nurs; 2023 Apr-Jun 01; 34(2):158-161. PubMed ID: 37276205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tianeptine Abuse Leading to an Episode of Psychosis: A Case Report and Literature Review.
    Karim A; Ioannou C
    J Psychiatr Pract; 2020 Mar; 26(2):146-148. PubMed ID: 32134888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tianeptine Abuse and Dependence: Case Report and Literature Review.
    Lauhan R; Hsu A; Alam A; Beizai K
    Psychosomatics; 2018 Nov; 59(6):547-553. PubMed ID: 30149933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tianeptine Abuse and Dependence in Psychiatric Patients: A Review of 18 Case Reports in the Literature.
    Springer J; Cubała WJ
    J Psychoactive Drugs; 2018; 50(3):275-280. PubMed ID: 29494783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Tianeptine Exposures Reported to the National Poison Data System - United States, 2000-2017.
    El Zahran T; Schier J; Glidden E; Kieszak S; Law R; Bottei E; Aaron C; King A; Chang A
    MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(30):815-818. PubMed ID: 30070980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poison control center experience with tianeptine: an unregulated pharmaceutical product with potential for abuse.
    Marraffa JM; Stork CM; Hoffman RS; Su MK
    Clin Toxicol (Phila); 2018 Nov; 56(11):1155-1158. PubMed ID: 29799284
    [No Abstract]   [Full Text] [Related]  

  • 11. Is it possible to be dependent to Tianeptine, an antidepressant? A case report.
    Kisa C; Bulbul DO; Aydemir C; Goka E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):776-8. PubMed ID: 17270334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Behavioral Effects of the Antidepressant Tianeptine Require the Mu-Opioid Receptor.
    Samuels BA; Nautiyal KM; Kruegel AC; Levinstein MR; Magalong VM; Gassaway MM; Grinnell SG; Han J; Ansonoff MA; Pintar JE; Javitch JA; Sames D; Hen R
    Neuropsychopharmacology; 2017 Sep; 42(10):2052-2063. PubMed ID: 28303899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Effects of the Atypical Tricyclic Antidepressant Tianeptine in Human Models of Opioid-induced Respiratory Depression.
    Algera H; van der Schrier R; Cavalla D; van Velzen M; Roozekrans M; McMorn A; Snape M; Horrigan JP; Evans S; Kiernan B; Sarton E; Olofsen E; Niesters M; Dahan A
    Anesthesiology; 2022 Oct; 137(4):446-458. PubMed ID: 35867853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addictive potential of Tianeptine - the threatening reality.
    Vadachkoria D; Gabunia L; Gambashidze K; Pkhaladze N; Kuridze N
    Georgian Med News; 2009 Sep; (174):92-4. PubMed ID: 19801742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal abstinence syndrome after maternal use of tramadol].
    de Wit D; Koomen-Botman I
    Ned Tijdschr Geneeskd; 2013; 157(9):A5610. PubMed ID: 23446156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of tianeptine use in patients with epilepsy.
    Moon J; Jung KH; Shin JW; Lim JA; Byun JI; Lee ST; Chu K; Lee SK
    Epilepsy Behav; 2014 May; 34():116-9. PubMed ID: 24739449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal opioid withdrawal syndrome.
    Sutter MB; Leeman L; Hsi A
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid treatment for opioid withdrawal in newborn infants.
    Zankl A; Martin J; Davey JG; Osborn DA
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD002059. PubMed ID: 34231914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Misuse of tianeptine: five cases of abuse].
    Leterme L; Singlan YS; Auclair V; Le Boisselier R; Frimas V
    Ann Med Interne (Paris); 2003 Nov; 154 Spec No 2():S58-63. PubMed ID: 14760227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.